---
title: "Presentation"
output:
  html_document:
    toc: true
    toc_float: true
    theme: united
---

# Questions

1. How does the site where the sample is taken from the solid tumor influence
the sample-to-sample heterogenity?

2. What are the different markers indicative of?
- Tumor-related: EGFR, p53
- Metabolic activity / proliferation: Ki-67, pS6
- Immunoregulatory proteins: PD-1, PD-L1, LAG3, IDO
-